Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.
We have sent an Open Letter to the Editor-in-Chief of the journal “Clinical Infectious Disease” to recommend an investigation and consequent retraction of a highly problematic meta-analysis titled “Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials” Re: Roman Y M, Burela P A, Paspuleti V, Piscoya A, Vidal J E and Hernandez A V (“Roman et al.). There are a number of identified, material concerns associated with this study that merit the imminent escalation to the journal’s leadership.
An “Accepted Manuscript” in Clinical Infectious Diseases, Roman et al. does not meet the standards of accuracy and integrity that any learned journal should demand. In asserting Conclusions that are not defensible on the evidence presented, it makes no contribution to science or medicine. In its present form, it should be retracted.
Unscrupulous Campaign Against Mounting Ivermectin Evidence
The irony in the authors’ point of view cannot be ignored while they declared:
“in the context of a misinformation inf...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).